Compare OTH & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OTH | ZTEK |
|---|---|---|
| Founded | 2012 | 2008 |
| Country | United States | Canada |
| Employees | 40 | N/A |
| Industry | Marine Transportation | Major Chemicals |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 64.2M | 68.8M |
| IPO Year | N/A | 2022 |
| Metric | OTH | ZTEK |
|---|---|---|
| Price | $2.58 | $0.58 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 42.6K | ★ 186.9K |
| Earning Date | 05-15-2026 | 02-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $600.18 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.70 | $0.40 |
| 52 Week High | $3.84 | $1.56 |
| Indicator | OTH | ZTEK |
|---|---|---|
| Relative Strength Index (RSI) | 48.69 | 45.61 |
| Support Level | $2.03 | $0.49 |
| Resistance Level | $2.73 | $0.60 |
| Average True Range (ATR) | 0.21 | 0.09 |
| MACD | 0.00 | -0.03 |
| Stochastic Oscillator | 61.36 | 5.94 |
Off The Hook YS Inc operates as a nationwide leader in the yacht and boat dealership industry, offering a comprehensive suite of services that spans the entire boat value chain. The company operates as two segments: Dealerships and Financial Services. Dealerships segment consists of Specializing in the buying, selling, and wholesaling of yachts and boats. Having a boat dealership created to run Yellow Fin sales in Miami. Financial Services segment consists of a recreational loan broker and lender providing financing solutions for individuals, dealerships, and brokerages. The Dealerships segment generates maximum revenue. The services of the company includes: Sell Your Boat, Brokerage, Marine Financing, Get Pre-Qualified, Warranty & Extended Coverage, and Wholesale.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.